This page contains exclusive content for the member of the following sections: TTS, IHCTAS. Log in to view.
Presenter: Suzanne T., Ildstad, Louisville, KY, USA
Authors: Suzanne T. Ildstad
Suzanne T. Ildstad, Institute for Cellular Therapeutics, University of Louisville, Louisville, KY, USA.
Learning objectives:
1. Understanding of chimerism and tolerance
2. Status of current studies in chimerism in VCA
Vascularized Composite Allotransplants (VCA) are immunologically complex units, often comprised of a bone marrow component and microenvironment. Chimerism induces donor-specific tolerance. This presentation will highlight the role of donor bone marrow chimerism in promoting acceptance of VCA. It will provide a review of the current status of chimerism from bench to the bedside.
By viewing the material on this site you understand and accept that:
The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada